Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Immunol. 2013 Nov 20;192(1):160–168. doi: 10.4049/jimmunol.1302502

Figure 3. E47hetp21het LT-HSCs exhibit decreased self-renewal and persistence in vivo.

Figure 3

(A) Serial transplantation was performed by transferring 2 × 106 BM cells from CD45.2+ WT, E47het, p21het or E47hetp21het mice into sub-lethally irradiated CD45.1+ C57BL/6 recipient mice to examine LT-HSC self-renewal and persistence through three rounds of serial transfer. (B) Mice were sacrificed at sixteen weeks post-transplant and the number of donor-derived BM LT-HSCs (CD45.2+ CD150+ CD48 LSK or CD45.2+ CD150+ flk2 LSK) was enumerated in primary, secondary or tertiary recipients. Graph is shown as mean ± SD of data pooled from n= 4–8 recipient mice for each genotype. (C) Mice were sacrificed two weeks after primary transplantation and the frequency of CD45.2+ total HSCs was examined. Data is shown as mean ± SD from n= 2–3 recipient mice per group. *p<0.05